Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia

Comprehensive genomic profiling examinations (CGPs) have recently been developed, and a variety of tumor-agnostic mutations have been detected, leading to the development of new molecular-targetable therapies across solid tumors. In addition, the elucidation of hereditary tumors, such as breast and...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hironori, Minami, Yosuke, Chi, SungGi, Utsu, Yoshikazu, Masuda, Shinichi, Aotsuka, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775249/
https://www.ncbi.nlm.nih.gov/pubmed/36551764
http://dx.doi.org/10.3390/biomedicines10123008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775249/
https://www.ncbi.nlm.nih.gov/pubmed/36551764
http://dx.doi.org/10.3390/biomedicines10123008

Ejemplares similares